Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the vital role MRNA technology played in COVID-19 vaccines.

Nobel Prize-winning mRNA technology, which saved millions of lives during the COVID-19 pandemic through vaccines, is now being redirected toward fighting cancer, cystic fibrosis, and other serious ...

Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, ...

WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...

Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research ...

The success of mRNA technology and its potential uses in therapeutics and preventative medical treatment may create a new technology ecosystem, the Harvard Business Review reported April 18. As has ...

BioNTech, founded in 2008 in Germany, has become a key player in the development of personalized mRNA cancer treatments. The emerging biotech's first commercial vaccine, for COVID-19, received its ...

Norovirus vaccines face significant hurdles, with virtually no success from past efforts from HilleVax and Vaxxart. But Moderna's mRNA-1403, now in Phase 3 trials, is based on the company's mRNA ...

A nurse reaches for a vial of Pfizer-BioNTech COVID-19 vaccine at a vaccine clinic in this March file photo. (Robyn Beck/AFP via Getty Images/TNS) Several states have effectively declared war on ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving COVID-19 shots. There's a catch: The mRNA ...

The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing. “After a ...

A team led by Rensselaer Polytechnic Institute (RPI) professors Georges Belfort, Ph.D. (PI), and Pankaj Karande, Ph.D. (co-PI ...